Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Covington
Merck
Julphar
Citi
Novartis
Argus Health
Johnson and Johnson
Deloitte
Baxter

Generated: February 25, 2018

DrugPatentWatch Database Preview

AZULFIDINE Drug Profile

« Back to Dashboard

When do Azulfidine patents expire, and what generic alternatives are available?

Azulfidine is a drug marketed by Pharmacia And Upjohn and is included in three NDAs.

The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

US Patents and Regulatory Information for AZULFIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn AZULFIDINE sulfasalazine SUSPENSION;ORAL 086983-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073-002 Apr 6, 1983 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn AZULFIDINE sulfasalazine SUSPENSION;ORAL 018605-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn AZULFIDINE sulfasalazine TABLET;ORAL 007073-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Chinese Patent Office
Johnson and Johnson
Express Scripts
Argus Health
Chubb
US Army
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot